Boardroom Alpha
Boardroom Alpha
GCTK · Additional Proxy Materials (DEFA14A) · Filed August 21, 2026

Glucotrack Inc — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
August 21, 2026
Ticker
GCTK
Accession
0001493152-26-039669
Boardroom Alpha · Filing insights

Glucotrack, Inc. reminds stockholders to vote; consult the filing for more details.

About Glucotrack Inc
Market cap
$4M
1Y TSR
−92.6%
3Y TSR
−93.8%
Board grade
D
Sector
Healthcare
CEO
Erik Emerson
Last annual meeting: Sep 11, 2026 · View full Glucotrack Inc profile →

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A INFORMATION

 

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

 

Filed by the Registrant
Filed by a Party other than the Registrant

 

Check the appropriate box:

 

Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material Pursuant to §240.14a-12

 

Glucotrack, Inc.

(Name of Registrant as Specified in Its Charter)

 

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

No fee required.
   
Fee paid previously with preliminary materials.
   
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 

 

 

 

 

 

**** IMPORTANT REMINDER TO VOTE YOUR SHARES ****

 

Dear Glucotrack, Inc. Stockholder:

 

The Glucotrack, Inc. Special Meeting of Stockholders is scheduled to be held on September 11, 2026. You are receiving this reminder because your votes were not yet processed at the time that it was mailed. If you have already voted, we would like to thank you for your vote.

 

Even if you plan to attend the Special Meeting, we urge you to vote your shares now, so your vote can be tabulated prior to the meeting.

 

Your vote is very important. The fastest and easiest way to vote is by telephone or online. Instructions on how to vote your shares by telephone or online are enclosed with this letter. Alternatively, you may sign and return the enclosed voting form in the envelope provided.

 

Please note that if you own shares of Glucotrack, Inc. stock in multiple accounts, you may receive multiple packages that are not duplicates. Please be sure to vote all your accounts of Glucotrack, Inc. shares.

 

If you have questions or need help voting your shares, please call our proxy solicitation firm, Sodali & Co., at 1-888-777-2094.

 

Thank you for your investment in Glucotrack, Inc., and for taking the time to vote your shares.

 

Sincerely,

 

Glucotrack, Inc.

 

 

From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Glucotrack Inc (GCTK)

Reference

Frequently asked questions

When did Glucotrack Inc file this DEFA14A?
Glucotrack Inc (GCTK) filed this Additional Proxy Materials (DEFA14A) with the SEC on August 21, 2026. The accession number assigned by EDGAR is 0001493152-26-039669.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Glucotrack, Inc. reminds stockholders to vote; consult the filing for more details. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Glucotrack Inc's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Glucotrack Inc has filed under CIK 1506983, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer